Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

997124

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Housing: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to promote public awareness of the the effect on people's health of poor quality indoor environments.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	184965
answer	answer is ministerial correction date of answer 06/11/2018 answer text <p>Public Health England (PHE) raises public awareness of the impacts of indoor air pollution by supporting activities that aim to change behaviour, such as the annual Clean Air Day, and is working with health partners, such as the National Institute for Health and Care Excellence, World Health Organization and Allergy UK, to improve the evidence on the health impacts of poor indoor air quality which will enhance advice to the public. PHE also promotes awareness about carbon monoxide through the use of blog posts, press releases and social media updates.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2018 16:28:25 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1010303

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Palliative Care: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that children with life-limiting conditions and their families have access to children's palliative care in the community out-of-hours and at weekends.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	192786
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>High quality community care is crucial to the delivery of end of life care services and our Choice Commitment, this includes out-of-hours and weekend services. Work undertaken by NHS England and system partners at a national level includes supporting sustainability and transformation partnership planning to address end of life care in all settings and providing key data on services; providing guidance on cost effective commissioning in end of life care; and providing practical examples of how out-of-hours access to palliative care, seven days a week, can be achieved.</p><p> </p><p>Going forward, we will have new measures in place to assess progress and hold commissioners to account, including a new indicator to measure deaths in hospital after three or more emergency admissions in the final 90 days of life, which will help us assess quality and provision of out of hospital care.</p><p> </p><p>NHS England is currently working with experts to develop new commissioning models for children and young people’s palliative care as it can be difficult for some clinical commissioning groups to meet the needs of this vulnerable group given the relatively small number of children concerned and their geographical spread.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/11/2018 15:06:17 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1438 label Biography information for Mr Kevan Jones

1010304

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England has put forward the inclusion of a maternal six-week postnatal check in negotiations on the General Medical Services contract; and what recent progress has been made in those negotiations.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	192896
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The inclusion of a requirement to carry out a six-week postnatal check for all mothers in the general medical services contract would need to be negotiated and agreed, as part of the annual contract negotiations. We have asked for this issue to be considered in the contract negotiations for 2019/20. The details of those negotiations are not generally discussed until an agreement on the way forward has been reached.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192897 question first answered 22/11/2018 11:40:36 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

1010305

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that a maternal six-week postnatal check is included in the General Medical Services contract; and what funding he plans to allocate for the provision of those checks.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	192897
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The inclusion of a requirement to carry out a six-week postnatal check for all mothers in the general medical services contract would need to be negotiated and agreed, as part of the annual contract negotiations. We have asked for this issue to be considered in the contract negotiations for 2019/20. The details of those negotiations are not generally discussed until an agreement on the way forward has been reached.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192896 question first answered 22/11/2018 11:40:36 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

1010306

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the shortage of EpiPen 0.3mg Auto-Injectors in (a) Yorkshire and the Humber and (b) England; and what steps he is taking to address that shortage.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	192898
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Department is working very closely with all the manufacturers of adrenaline auto-injectors, the Medicines and Health products Regulatory Agency, and NHS England and the supply situation is improving. Supplies of EpiPen 0.3mg and the alternative adrenaline auto-injectors are currently available across the country in volumes that are sufficient to meet normal United Kingdom requirements and further deliveries of all three brands of adrenaline auto-injectors are expected in the coming weeks. Comprehensive information and guidance, with input from National Health Service allergy experts has been cascaded to all healthcare professionals, schools, patient groups and frontline NHS services, which provides information about the supply issue, clinical management options and advice to share with patients. We have put this process in place to ensure that those patients with the greatest clinical need have been prioritised to receive new supplies of adrenaline auto-injectors.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192899 question first answered 22/11/2018 15:07:15 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

1010307

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on the health of children under 16 of the national shortage of EpiPen 0.3mg Auto-Injectors; and what plans he has in place to reduce that shortage.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	192899
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Department is working very closely with all the manufacturers of adrenaline auto-injectors, the Medicines and Health products Regulatory Agency, and NHS England and the supply situation is improving. Supplies of EpiPen 0.3mg and the alternative adrenaline auto-injectors are currently available across the country in volumes that are sufficient to meet normal United Kingdom requirements and further deliveries of all three brands of adrenaline auto-injectors are expected in the coming weeks. Comprehensive information and guidance, with input from National Health Service allergy experts has been cascaded to all healthcare professionals, schools, patient groups and frontline NHS services, which provides information about the supply issue, clinical management options and advice to share with patients. We have put this process in place to ensure that those patients with the greatest clinical need have been prioritised to receive new supplies of adrenaline auto-injectors.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192898 question first answered 22/11/2018 15:07:15 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

1010370

registered interest
date	19/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hearing Impairment: Digital Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England plans to approve an app to support patients in managing hearing loss; and if he will make a statement.
tabling member constituency	East Ham
tabling member printed	Stephen Timms
uin	192697
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>There are no hearing loss specific apps yet on the apps library.</p><p> </p><p>Developers of apps with health applications can seek National Health Service approval for them through the NHS England Digital Assessment Questionnaire process. Having gone through this process, successful apps will be given an NHS accreditation and uploaded to the NHS Apps and Wearables library. NHS England is in discussions with a number of companies to go through the apps library process.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 22/11/2018 15:05:05 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	163 label Biography information for Sir Stephen Timms

1008477

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gambling: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 9 November 2018 to Question 186383 on Gambling: Rehabilitation, what steps his Department is taking to ensure that local authorities are able to adequately support people who have gambling addictions.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	192126
answer	answer is ministerial correction date of answer 21/11/2018 answer text <p>In summer 2018, Public Health England and the Local Government Association published a guide for local authorities which provides an overview of gambling-related harms and how councils can begin to try to help local residents who are impacted by it. It provides information on the current framework for prevention and support, information on the regulatory tools councils can use to help tackle gambling-related harm and the role of public health.</p><p> </p><p>‘Tackling Gambling Related Harm: A whole council approach’ is available to view at the following link:</p><p> </p><p><a href="https://www.local.gov.uk/sites/default/files/documents/10.28%20GUIDANCE%20ON%20PROBLEM%20GAMBLING_07.pdf" target="_blank">https://www.local.gov.uk/sites/default/files/documents/10.28%20GUIDANCE%20ON%20PROBLEM%20GAMBLING_07.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/11/2018 14:34:06 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

1008486

registered interest
date	16/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Preventive Medicine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the document entitled Prevention is better than cure, published by his Department on 5 November 2018, what the timetable is for the Green Paper on prevention.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	192129
answer	answer is ministerial correction date of answer 21/11/2018 answer text <p>On 5 November the Government’s Vision for Prevention was published (entitled ‘Prevention is better than cure’). This set out how prevention will be placed at the heart of our health and social care system for the long term. This vision is just the beginning - much more needs to be done to make it a reality. Next year, the Government will work with stakeholders to publish a Green Paper on prevention setting out government plans in more detail, and seeking a wide range of views on what action is most needed. The Department will work closely across Government, and with our partners in health, social care, local government, housing and the voluntary sector.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/11/2018 14:34:57 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

1007757

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Levetiracetam
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of the UK leaving the EU on the availability of Keppra for people with epilepsy.
tabling member constituency	Crewe and Nantwich
tabling member printed	Laura Smith
uin	191984
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The United Kingdom’s position on medicines regulation remains clear. We want to retain a close working partnership with the European Union to ensure that medicines remain available to UK patients in a safe and timely manner. We have been clear that this involves us making sure our regulators continue to work together, as they do with regulators internationally. As the Prime Minister has said, we intend to to explore with the EU the terms on which the UK could remain part the European Medicines Agency.</p><p> </p><p>Until we can be certain of the outcome of Brexit negotiations our duty as a responsible Government is to prepare for all eventualities, including ‘no deal’. On 23 August 2018, therefore, the Department wrote to all pharmaceutical companies that supply the United Kingdom with prescription only or pharmacy medicines from, or via, the European Union/European Economic Area, asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019 in the event of a no-deal scenario.</p><p> </p><p>Since then, we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a no-deal Brexit.</p><p> </p><p>We understand that the medicine Keppra is important to many people in this country. However, the Department recognises that through its medicines supply contingency programme it is requesting sensitive commercial information from pharmaceutical companies. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company, specific medicine or their supply routes into the public domain.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 11:54:10 answering member 4067 label Biography information for Steve Brine
tabling member	4648 label Biography information for Laura Smith